发明授权
US5891456A Glyceryl monosterate based biodegradable implants for site-specific
delivery of drugs
失效
基于单体甘油酯的生物可降解植入物用于药物的特异性递送
- 专利标题: Glyceryl monosterate based biodegradable implants for site-specific delivery of drugs
- 专利标题(中): 基于单体甘油酯的生物可降解植入物用于药物的特异性递送
-
申请号: US885675申请日: 1997-06-30
-
公开(公告)号: US5891456A公开(公告)日: 1999-04-06
- 发明人: Jaymin C. Shah , Saleh Allababidi
- 申请人: Jaymin C. Shah , Saleh Allababidi
- 申请人地址: SC Charleston
- 专利权人: Medical University of South Carolina
- 当前专利权人: Medical University of South Carolina
- 当前专利权人地址: SC Charleston
- 主分类号: A61K9/00
- IPC分类号: A61K9/00 ; A61K9/20 ; A61K9/28 ; A61R2/02 ; A01N25/12 ; A61K47/30
摘要:
A method to administer a drug locally to a subject in which biodegradable dosage forms that contain the drug are implanted at a localized site beneath the skin of the subject whereupon the dosage forms release the drug over a desired period of time at a substantially continuous rate. Glyceryl monostearate based compositions that accomplish the method are also provided. Compositions are further provided that affect the release profile or release duration of drugs that are released from the compositions, as are methods that employ these varying release profiles to provide implantable dosage forms that release drugs at a prescribed rate over a prescribed period of time. The compositions are particularly well adapted to implantable dosage forms because they biodegrade quickly to an acceptable level after delivering the drug.
公开/授权文献
- US5215290A Plastic fence 公开/授权日:1993-06-01
信息查询